{"legislative_session": "104th", "identifier": "HB3645", "title": "EMS-OPIOID OVERDOSE REPORTS", "from_organization": "~{\"classification\": \"lower\"}", "classification": ["bill"], "subject": [], "abstracts": [{"note": "", "abstract": "Amends the Emergency Medical Services (EMS) Systems Act. In provisions concerning opioid overdose reporting, provides that overdose information reported by a covered vehicle service provider shall not be used in an opioid use-related criminal investigation, prosecution, welfare checks, or warrant checks of the individual who was treated by the covered vehicle service provider personnel for experiencing the suspected or actual overdose. Provides that any misuse of the information reported by a covered vehicle service provider shall result in, but is not limited to, the Department of Transportation reporting misuse to the Washington/Baltimore High Intensity Drug Trafficking Area Overdose Detection Mapping Application or similar technology platform. Permits the Department of Health to adopt rules to set forth standards under which misuse of access may be reported to the Washington/Baltimore High Intensity Drug Trafficking Area Overdose Detection Map or similar platform based on misuse or misconduct by a covered vehicle service provider or other individual or entity at the discretion of the Department. Provides that no data that allows for or creates a risk of identification of an individual or individuals experiencing a suspected or actual overdose treated by the covered vehicle service provider personnel shall be submitted to the Washington/Baltimore High Intensity Drug Trafficking Area Overdose Detection Mapping Application or Similar technology platform. Provides that covered vehicle service provider personnel may report overdose surveillance through an identified technology platform for the use of overdose surveillance under exceptions to HIPAA and the reported data shall only be used to support public safety and public health efforts. Sets forth additional provisions concerning requirements for the Department concerning opioid overdose reporting."}], "other_titles": [], "other_identifiers": [], "actions": [{"description": "Filed with the Clerk by Rep. Michael J. Kelly", "date": "2025-02-07", "organization_id": "~{\"classification\": \"lower\"}", "classification": ["filing"], "related_entities": []}, {"description": "First Reading", "date": "2025-02-18", "organization_id": "~{\"classification\": \"lower\"}", "classification": ["reading-1"], "related_entities": []}, {"description": "Referred to Rules Committee", "date": "2025-02-18", "organization_id": "~{\"classification\": \"lower\"}", "classification": [], "related_entities": []}, {"description": "Added Co-Sponsor Rep. Martin J. Moylan", "date": "2025-03-06", "organization_id": "~{\"classification\": \"lower\"}", "classification": [], "related_entities": []}, {"description": "Added Co-Sponsor Rep. Dave Vella", "date": "2025-03-06", "organization_id": "~{\"classification\": \"lower\"}", "classification": [], "related_entities": []}, {"description": "Assigned to Public Health Committee", "date": "2025-03-11", "organization_id": "~{\"classification\": \"lower\"}", "classification": ["referral-committee"], "related_entities": []}, {"description": "Added Chief Co-Sponsor Rep. Nicolle Grasse", "date": "2025-03-19", "organization_id": "~{\"classification\": \"lower\"}", "classification": [], "related_entities": []}, {"description": "Do Pass / Short Debate Public Health Committee;  009-000-000", "date": "2025-03-20", "organization_id": "~{\"classification\": \"lower\"}", "classification": [], "related_entities": []}, {"description": "Placed on Calendar 2nd Reading - Short Debate", "date": "2025-03-20", "organization_id": "~{\"classification\": \"lower\"}", "classification": ["reading-2"], "related_entities": []}], "sponsorships": [{"name": "Michael J. Kelly", "classification": "primary", "entity_type": "person", "primary": true, "person_id": "~{\"chamber\": \"lower\", \"name\": \"Michael J. Kelly\"}", "organization_id": null}, {"name": "Nicolle Grasse", "classification": "cosponsor", "entity_type": "person", "primary": false, "person_id": "~{\"chamber\": \"lower\", \"name\": \"Nicolle Grasse\"}", "organization_id": null}, {"name": "Martin J. Moylan", "classification": "cosponsor", "entity_type": "person", "primary": false, "person_id": "~{\"chamber\": \"lower\", \"name\": \"Martin J. Moylan\"}", "organization_id": null}, {"name": "Dave Vella", "classification": "cosponsor", "entity_type": "person", "primary": false, "person_id": "~{\"chamber\": \"lower\", \"name\": \"Dave Vella\"}", "organization_id": null}], "related_bills": [], "versions": [{"note": "Introduced", "links": [{"url": "https://beta.ilga.gov/documents/legislation/104/HB/PDF/10400HB3645.pdf", "media_type": "application/pdf"}, {"url": "https://beta.ilga.gov/Legislation/BillStatus/FullText?LegDocId=202182&DocName=10400HB3645&DocNum=3645&DocTypeID=HB&LegID=162394&GAID=18&SessionID=114&SpecSess=&Session=&Print=1", "media_type": "text/html"}], "date": "", "classification": ""}], "documents": [], "citations": [], "sources": [{"url": "https://beta.ilga.gov/Legislation/BillStatus?DocNum=3645&GAID=18&DocTypeID=HB&LegId=162394&SessionID=114", "note": ""}], "extras": {}, "_id": "44ffbe52-1729-11f0-9eaa-86812f74cec2"}